Comments
We refer to our letter dated June 27, 2018, informing you about the Board Meeting of Novartis India Limited that was scheduled for today. Please note that the Board of Directors of the Company met today at 11.00 a.m. and the meeting concluded at 02.30 p.m. The following items were considered and approved: 1. Financial results for the quarter ended June 30, 2018 along with the Limited Review Report provided by M/s, Deloitte Haskins & Sells LLP, Statutory Auditors of the Company. 2. Change in the registered office of the Company within local limits of Mumbai, from existing premises of Sandoz House, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 018 to The Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 effective August 6, 2018, onwards. We have made arrangements for publishing an extract of the above mentioned financial results as per the format prescribed under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements),
Pdf Link: Novartis India Ltd. - Results For The Quarter Ended June 30, 2018
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.